Cleveland, OHNCT07104630Now EnrollingIRB Ready

Non-small Cell Lung Cancer Stage III Clinical Trial in Cleveland, OH

Access cutting-edge non-small cell lung cancer stage iii treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.

Sponsored by Case Comprehensive Cancer Center

Quick Self-Assessment

See if you qualify for this Cleveland location

Preparing your pre-screening questions…

Expert Care in Cleveland

Access non-small cell lung cancer stage iii specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-small cell lung cancer stage iii treatment provided free

Apply for This Cleveland Location

Check if you qualify for this non-small cell lung cancer stage iii clinical trial in Cleveland, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cleveland

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cleveland site if eligible
  4. 4Begin participation

About This Non-small Cell Lung Cancer Stage III Study in Cleveland

This study is for people who have previously been diagnosed with advanced stage non-small cell lung cancer (NSCLC). Many people with advanced stage NSCLC have trouble breathing and feel tired. People may be eligible for this study if they have advanced stage NSCLC and feel short of breath some of the time. NSCLC survivors may also experience things like fatigue and a lower quality of life. Pulmonary rehabilitation is a type of supportive treatment that may improve these symptoms. This study has two parts. The first part is a randomized trial where half of the participants receive eight weeks of pulmonary rehabilitation. The other half of participants do not do pulmonary rehabilitation and instead receive the treatment that their doctors would normally recommend. The purpose of this part of the research study is to understand if pulmonary rehabilitation can help people with advanced stage NSCLC have better functioning and less shortness of breath. The other part of the research study is an interview study. The purpose of doing interviews is to understand any challenges or obstacles that people with advanced stage NSCLC may have regarding pulmonary rehabilitation, as well as oncology care providers have with their participants going to pulmonary rehabilitation.

Sponsor: Case Comprehensive Cancer Center

Who Can Participate

Inclusion Criteria

Participants must have histologically confirmed NSCLC, Stages III or IV treated with palliative intent
Adults ≥ 18 years of age
ECOG performance status ≤ 3
Clinical stability: defined as no clinical/radiographic progression within the last three months
Self-reported dyspnea, defined as score ≥ 2 on the modified Medical Research Council (mMRC) Dyspnea Scale
Participants must be fluent in written and spoken English

Exclusion Criteria

Participants being treated with curative intent for locally advanced NSCLC or oligometastatic NSCLC with concurrent chemotherapy and radiation will be excluded
Participants have evidence of clinical and/or radiographic progression
Mental impairment leading to inability to complete study requirements
High risk of fracture or spine instability (Mirels score ≥7 or SINS ≥7)
Any of the following cardiac exclusion criteria:
Class II, III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system
History of acute coronary syndromes (including myocardial infarction and unstable angina), coronary angioplasty or stenting within the past 6 months prior to the start of radiation therapy
Uncontrolled arrhythmias; individuals with rate-controlled atrial fibrillation for \> 1 month prior to start of radiation therapy may be eligible
Acute myocarditis, pericarditis, or endocarditis
Acute pulmonary embolus or pulmonary infarction within the last 3 months
Acute thrombosis of lower extremities within the last 3 months
Suspected dissecting aneurysm
Pulmonary edema
Respiratory failure
Acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cleveland?

Yes, this clinical trial (NCT07104630) has an active research site in Cleveland, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-small Cell Lung Cancer Stage III Treatment Options in Cleveland, OH

If you're searching for non-small cell lung cancer stage iii treatment options in Cleveland, OH, this clinical trial (NCT07104630) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer stage iii specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-small cell lung cancer stage iii clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Cleveland, OH

See all lung cancer clinical trials recruiting in Cleveland — not just this study.

Browse Lung Cancer Trials in Cleveland

Ready to Join in Cleveland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cleveland, OH